Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records.

Background: To assess the prevalence of menopausal symptoms among women prescribed hormone therapy (HT) using electronic medical record data from a regional healthcare organization.Methods: Retrospective data from the Reliant Medical Group from 1/1/2006-12/31/2011 were assessed for 102 randomly-sele...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Women's Health Vol. 15; no. 1; pp. 58 - 59
Autores principales: Sussman, Matthew, Trocio, Jeffrey, Best, Craig, Mirkin, Sebastian, Bushmakin, Andrew G, Yood, Robert, Friedman, Mark, Menzin, Joseph, Louie, Michael
Formato: Journal Article
Publicado: BioMed Central 2015
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Background: To assess the prevalence of menopausal symptoms among women prescribed hormone therapy (HT) using electronic medical record data from a regional healthcare organization.Methods: Retrospective data from the Reliant Medical Group from 1/1/2006-12/31/2011 were assessed for 102 randomly-selected patients. Study eligibility criteria included: females aged 45 to 65; prescribed oral or transdermal HT; no history of breast cancer, venous thromboembolism, stroke, gynecological cancer, or hysterectomy; continuously enrolled in the health plan for 1 year before and after the first observed HT prescription. Prevalence of menopause-related symptoms was analyzed descriptively at both the patient and visit levels.Results: Mean age of patients was 54 years. The most common menopausal symptoms were: hot flushes (40%), night sweats (17%), insomnia (16%), vaginal dryness (13%), mood disorders (12%), and weight gain (12%). Among the 102 patients, 163 individual visits listing menopausal symptoms were identified, of which hot flushes (71 visits) were the most common symptom identified.Conclusion: Our findings provide recent data on the types of menopausal symptoms experienced by mid-life women prescribed HT. Electronic medical records may be a rich source of data for future studies of menopausal symptoms in this population.